• 3
    Haplo
    Score
  • 0
    Triplo
    Score

Gene Facts External Data Attribution

HGNC Symbol
HPRT1 (HGNC:5157) HGNC Entrez Ensembl OMIM UCSC Uniprot GeneReviews LOVD LSDB ClinVar
HGNC Name
hypoxanthine phosphoribosyltransferase 1
Gene type
protein-coding gene
Locus type
gene with protein product
Previous symbols
HPRT
Alias symbols
HGPRT
%HI
8.48(Read more about the DECIPHER Haploinsufficiency Index)
pLI
0.94(Read more about gnomAD pLI score)
LOEUF
0.34(Read more about gnomAD LOEUF score)
Cytoband
Xq26.2-q26.3
Genomic Coordinates
GRCh37/hg19: chrX:133594195-133634698 NCBI Ensembl UCSC
GRCh38/hg38: chrX:134460165-134500668 NCBI Ensembl UCSC
MANE Select Transcript
NM_000194.3 ENST00000298556.8 (Read more about MANE Select)
Function
Converts guanine to guanosine monophosphate, and hypoxanthine to inosine monophosphate. Transfers the 5-phosphoribosyl group from 5- phosphoribosylpyrophosphate onto the purine. Plays a central role in the generation of purine nucleotides through the purine salvage pathway. (Source: Uniprot)

Dosage Sensitivity Summary (Gene)

Dosage ID:
ISCA-16833
ClinGen Curation ID:
CCID:007295
Curation Status:
Complete
Issue Type:
Dosage Curation - Gene
Haploinsufficiency:
Sufficient Evidence for Haploinsufficiency (3)
Triplosensitivity:
No Evidence for Triplosensitivity (0)
Last Evaluated:
01/13/2021

Haploinsufficiency (HI) Score Details

HI Score:
3
HI Evidence Strength:
Sufficient Evidence for Haploinsufficiency (Disclaimer)
HI Disease:
HI Evidence:
  • PUBMED: 11018746
    Jinnah (2000) reviewed 271 inherited mutations causing HPRT deficiency. The cases include over 90 loss of function variants (nonsense variants, splice site varaints, frameshifts and exonic deletions). They show that pathogenic HPRT1 variants are associated with a spectrum of disease that ranges from hyperuricemia alone to hyperuricemia with profound neurological and behavioral dysfunction. Loss of function variants result in the more severe end of the spectrum causing Lesch-Nyhan syndrome and since the disease is inherited in an X-linked recessive manner, nearly all cases were males. However, at least five females with a typical LND phenotype (due to skewed X-inactivation) have been reported. Female carriers although typically unaffected may develop symptoms of hyperuricemia in later years.
HI Evidence Comments:
Lesch-Nyhan syndrome is associated with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior. Megaloblastic anemia has been found in some patients. Although female carriers are typically unaffected they may develop symptoms of hyperuricemia in later years. See GeneReviews for additional information.
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Triplosensitivity (TS) Score Details

TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Genomic View

Select assembly: (NC_000023.10) (NC_000023.11)